{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T16:10:10Z","timestamp":1717690210444},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.lpm.2014.07.026","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T06:18:13Z","timestamp":1421216293000},"page":"271-283","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Psychotropes pendant la grossesse et l\u2019allaitement\u00a0: mise au point pratique"],"prefix":"10.1016","volume":"44","author":[{"given":"C\u00e9line","family":"Bascoul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludivine","family":"Franchitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Parant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Raynaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2014.07.026_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1176\/appi.focus.10.1.3","article-title":"Psychopharmacology in pregnancy and postpartum","volume":"10","author":"Robinson","year":"2012","journal-title":"Focus"},{"key":"10.1016\/j.lpm.2014.07.026_bib0010","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/AOG.0b013e3181ba0632","article-title":"The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and gynecologists","volume":"114","author":"Yonker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0015","series-title":"Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk","first-page":"61","author":"Briggs","year":"2011"},{"key":"10.1016\/j.lpm.2014.07.026_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.2011.04072.x","article-title":"Clomipramine concentration and withdrawal symptoms in 10\u00a0neonates","volume":"73","author":"ter Horst","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0025","doi-asserted-by":"crossref","first-page":"e001148","DOI":"10.1136\/bmjopen-2012-001148","article-title":"Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study","volume":"2","author":"Jimenez-Solem","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.lpm.2014.07.026_bib0030","first-page":"339","article-title":"Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study","volume":"23","author":"Pedersen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2014.07.026_bib0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3810\/pgm.2010.07.2175","article-title":"Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update","volume":"122","author":"Tuccori","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1016\/j.lpm.2014.07.026_bib0040","first-page":"978","article-title":"Antidepressant in pregnancy: a systematic review","volume":"44","author":"Udechuku","year":"2010","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.lpm.2014.07.026_bib0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bdra.20643","article-title":"Paroxetine exposure during pregnancy and the risk of cardiac malformations: what is the evidence?","volume":"88","author":"Berard","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/bdra.20655","article-title":"Paroxetine exposure during pregnancy and cardiac malformations","volume":"88","author":"Scialli","year":"2010","journal-title":"Birth Defect Res A Clin Mol Teratol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bdra.20627","article-title":"First trimester paroxetine use and the prevalence of congenital, specifically cardiac defects: a meta-analysis of epidemiological studies","volume":"88","author":"Wurst","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/CLEP.S9256","article-title":"Use of selective serotonin reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis","volume":"2","author":"Kornum","year":"2010","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/156720110790396508","article-title":"Gestational exposure to antidepressants and the risk of spontaneous abortion: a review","volume":"7","author":"Broy","year":"2010","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.lpm.2014.07.026_bib0070","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data","volume":"40","author":"Reis","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.lpm.2014.07.026_bib0075","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2125.2012.04196.x","article-title":"Antidepressant use during pregnancy and the risk of pregnancy induced hypertension","volume":"74","author":"De Vera","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0080","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archpediatrics.2009.164","article-title":"Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes","volume":"163","author":"Lund","year":"2009","journal-title":"Arch Pediatric Adolesc Med"},{"key":"10.1016\/j.lpm.2014.07.026_bib0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/157340411794474784","article-title":"Antidepressant use during breastfeeding","volume":"7","author":"Berle","year":"2011","journal-title":"Curr Womens Health Rev"},{"key":"10.1016\/j.lpm.2014.07.026_bib0090","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/070674371005501000","article-title":"Association between antidepressant use during pregnancy and infants born small for gestational age","volume":"55","author":"Ramos","year":"2010","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.lpm.2014.07.026_bib0095","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.4088\/JCP.12l08013","article-title":"Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report","volume":"73","author":"Einarson","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.lpm.2014.07.026_bib0100","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2125.2010.03714.x","article-title":"Neonatal seizures on EEG after in utero exposure to venlafaxine","volume":"70","author":"Hoppenbrouwers","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ptr.1880","article-title":"St. John's wort modulation and developmental expression of multidrug transporters in the rat","volume":"20","author":"Garrovo","year":"2006","journal-title":"Phytother Res"},{"key":"10.1016\/j.lpm.2014.07.026_bib0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14740338.2010.506478","article-title":"Diazepam effects on non-syndromic cleft lip with or without palate: epidemiological studies, clinical findings, genes and extracellular matrix","volume":"10","author":"Marinucci","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.lpm.2014.07.026_bib0115","first-page":"163","article-title":"The effects of benzodiaz\u00e9pines in pregnancy","volume":"110","author":"Lepee","year":"2010","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.lpm.2014.07.026_bib0120","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ajog.2009.06.061","article-title":"Risk of preterm delivery and other adverse perinatal outcome in relation to maternal use of psychotropic medications during pregnancy","volume":"201","author":"Calderon-Margalit","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2515\/therapie:2007030","article-title":"Exposition in utero \u00e0 des substances psycho actives: r\u00e9sultats de l\u2019\u00e9tude \u201cNENUPHAR\u201d 1","volume":"62","author":"Lacroix","year":"2007","journal-title":"Therapie"},{"key":"10.1016\/j.lpm.2014.07.026_bib0130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jpeds.2012.03.003","article-title":"Neonatal benzodiazepines exposure during breastfeeding","volume":"161","author":"Kelly","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.lpm.2014.07.026_bib0135","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/JCP.0b013e3182197055","article-title":"Are hypnotic benzodiazepine receptor agonists teratogenic in human?","volume":"31","author":"Wikner","year":"2011","journal-title":"J Clin Psychopharmacol"},{"issue":"S1","key":"10.1016\/j.lpm.2014.07.026_bib0140","first-page":"424","article-title":"Case report: in utero exposure and safe breastfeeding in two premature twins of a chronically treated mother with high doses of zopiclone","volume":"24","author":"Mathieu","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0145","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"The transfert of drugs and other chemicals into human breast milk","volume":"108","author":"Committee on Drugs","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.lpm.2014.07.026_bib0150","series-title":"Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk","first-page":"707","author":"Briggs","year":"2011"},{"key":"10.1016\/j.lpm.2014.07.026_bib0155","series-title":"Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk","first-page":"327","author":"Brigg","year":"2008"},{"key":"10.1016\/j.lpm.2014.07.026_bib0160","series-title":"Drug Safety Communication: antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns [serial online]","author":"FDA","year":"2011"},{"key":"10.1016\/j.lpm.2014.07.026_bib0165","first-page":"308","article-title":"Antipsychotic drugs and breastfeeding","volume":"10","author":"Klinger","year":"2013","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.lpm.2014.07.026_bib0170","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1345\/aph.1D485","article-title":"Clinical utilization of atypical antipsychotics in pregnancy and lactation","volume":"38","author":"Gentile","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.lpm.2014.07.026_bib0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/2045125312460395","article-title":"Neonatal hypoglycaemia following maternal olanzapine therapy during pregnancy: a case report","volume":"2","author":"Rowe","year":"2012","journal-title":"Therap Adv Psychopharmacol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0180","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pnpbp.2007.09.005","article-title":"Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats","volume":"32","author":"Zuo","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.lpm.2014.07.026_bib0185","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.reprotox.2012.05.048","article-title":"Severe neutropenia in a newborn after clozapine therapy during pregnancy","volume":"34","author":"Borisch","year":"2012","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0190","first-page":"913","article-title":"Fetal heart rate variability and clozapine treatment","volume":"40","author":"Coston","year":"2012","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.lpm.2014.07.026_bib0195","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.arcped.2012.06.019","article-title":"Case report: neonatal delayed peristalsis after in utero exposure to clozapine","volume":"19","author":"Moreno-Bruna","year":"2012","journal-title":"Arch Pedriatr"},{"key":"10.1016\/j.lpm.2014.07.026_bib0200","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0032-1312591","article-title":"Aripiprazole use in early pregnancy: a case report","volume":"45","author":"Widschwendter","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.lpm.2014.07.026_bib0205","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archgenpsychiatry.2012.160","article-title":"Prenatal antipsychotic exposure and neuromotor performance during infancy","volume":"69","author":"Johnson","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.lpm.2014.07.026_bib0210","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2174\/138161206776389804","article-title":"Teratogenic and developmental effects of lithium","volume":"12","author":"Giles","year":"2006","journal-title":"Curr Pharm Design"},{"key":"10.1016\/j.lpm.2014.07.026_bib0215","first-page":"42","article-title":"The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad spectrum psychotropics","volume":"63","author":"Ernst","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.lpm.2014.07.026_bib0220","series-title":"Valproate anti-seizure products: drug safety communication\u00a0\u2013\u00a0Contraindicated for pregnant women for prevention of migraine headaches [serial online]","author":"FDA","year":"2013"},{"key":"10.1016\/j.lpm.2014.07.026_bib0225","first-page":"665","article-title":"Clinical enquiries. What's the best strategy for bipolar disorder during pregnancy?","volume":"56","author":"Minick","year":"2007","journal-title":"J Fam Pract"},{"key":"10.1016\/j.lpm.2014.07.026_bib0230","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.0b013e3181a6b325","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2014.07.026_bib0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jocn.2011.08.003","article-title":"Teratogenicity of the newer antiepileptic drugs\u00a0\u2013\u00a0The Australian experience","volume":"19","author":"Vajda","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.lpm.2014.07.026_bib0240","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2014.07.026_bib0245","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.yebeh.2012.05.010","article-title":"Differential effects of antiepileptic drugs on neonatal outcome","volume":"24","author":"Pennel","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.lpm.2014.07.026_bib0250","first-page":"67","article-title":"Lithium and artificial breastmilk; or is maternal breastfeeding better?","volume":"75","author":"Marin Gabriel","year":"2011","journal-title":"An Pediatr"},{"key":"10.1016\/j.lpm.2014.07.026_bib0255","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ogc.2014.02.005","article-title":"Buprenorphine and methadone for opioid addiction during pregnancy","volume":"41","author":"Mozurkewich","year":"2014","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.lpm.2014.07.026_bib0260","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1176\/appi.ps.201300256","article-title":"Medication-assisted treatment with bupr\u00e9norphine: assessing the evidence","volume":"65","author":"Thomas","year":"2014","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.lpm.2014.07.026_bib0265","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archgenpsychiatry.2011.2333","article-title":"Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes","volume":"69","author":"El Marroun","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.lpm.2014.07.026_bib0270","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/acps.12042","article-title":"Antidepressant use in pregnancy: a critical review focused on risks and controversies","volume":"127","author":"Byatt","year":"2013","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.lpm.2014.07.026_bib0275","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.pra.0000351878.45260.94","article-title":"Use and safety of antipsychotic drugs during pregnancy","volume":"15","author":"Einarson","year":"2009","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.lpm.2014.07.026_bib0280","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","article-title":"Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation","volume":"164","author":"Viguera","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.lpm.2014.07.026_bib0285","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.earlhumdev.2011.09.013","article-title":"Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies","volume":"88","author":"Van der Lugt","year":"2012","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.lpm.2014.07.026_bib0290","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6\u00a0years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2014.07.026_bib0295","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ogc.2014.02.010","article-title":"Neonatal opioid withdrawal syndrome","volume":"41","author":"Sutter","year":"2014","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.lpm.2014.07.026_bib0300","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/0890334413517748","article-title":"The wellbeing of infants exposed to bupr\u00e9norphine via breast milk at 4\u00a0weeks of age","volume":"30","author":"Gower","year":"2014","journal-title":"J Hum Lact"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214006095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214006095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T15:19:05Z","timestamp":1717687145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498214006095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0755498214006095"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2014.07.026","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychotropes pendant la grossesse et l\u2019allaitement\u00a0: mise au point pratique","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}